7-(1,1-DIMETHYLETHYL)-6-((1-ETHYL-1H-1,2,4-TRIAZOL-5-YL)METHOXY)-3-(2-FLUOROPHENYL)-1-.BETA.-D-GLUCOPYRANURONOSYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZINIUM
UNII 02X1GF8X88
Substance Identification & Data
This profile provides standardized clinical and technical data for 7-(1,1-dimethylethyl)-6-((1-ethyl-1h-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1-.beta.-d-glucopyranuronosyl-1,2,4-triazolo(4,3-b)pyridazinium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 02X1GF8X88.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 474319-48-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C26H30FN7O7 ULQVHFNZCFUDCZ-NABGWTBKSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 7-(1,1-dimethylethyl)-6-((1-ethyl-1h-1,2,4-triazol-5-yl)methoxy)-3-(2-fluorophenyl)-1-.beta.-d-glucopyranuronosyl-1,2,4-triazolo(4,3-b)pyridazinium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.